| STML - Stemline Therapeutics Inc (Healthcare: Biotechnology) | Projected Earnings Date: 2020-11-02 (Delayed quote data ) |
|
|
|||||||||||||||||
|
|
|
| Company Profile | |
| Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. It is involved in the business of discovering, acquiring and developing and commercializing therapeutics for oncology indications of unmet medical need. It is developing clinical stage product candidates namely SL-401, SL-801, and SL-701. The company is also involved in advancing its clinical stage programs, expanding and strengthening its intellectual property portfolio, identifying and acquiring additional product and technology rights. | |
| Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. |